Cargando…

Circulating HFMD-Associated Coxsackievirus A16 Is Genetically and Phenotypically Distinct from the Prototype CV-A16

Human enteroviruses (HEV) have been linked to hand, foot, and mouth disease (HFMD) in the Pacific and Southeast Asia for decades. Many cases of HFMD have been attributed to coxsackievirus A16 (CV-A16, CA16), based on only partial viral genome determination. Viral phenotypes are also poorly defined....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Wei, Guo, Haoran, Li, Jingliang, Ren, Sangsang, Wei, Zhenhong, Bao, Wanguo, Hu, Xiaoming, Zhao, Ke, Zhang, Wenyan, Zhou, Yulai, Sun, Fei, Markham, Richard, Yu, Xiao-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988102/ https://www.ncbi.nlm.nih.gov/pubmed/24736564 http://dx.doi.org/10.1371/journal.pone.0094746

Ejemplares similares

Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates
por: Li, Jingliang, et al.
Publicado: (2014)

Seroprevalence of Human Enterovirus 71 and Coxsackievirus A16 in Guangdong, China, in Pre- and Post-2010 HFMD Epidemic Period
por: Li, Wei, et al.
Publicado: (2013)

Coxsackievirus A16 Infection Induces Neural Cell and Non-Neural Cell Apoptosis In Vitro
por: Li, Zhaolong, et al.
Publicado: (2014)

Circulating Coxsackievirus A16 Identified as Recombinant Type A Human Enterovirus, China
por: Zhao, Ke, et al.
Publicado: (2011)

Whole-genome sequencing and phylogenetic analysis of coxsackievirus-A16 strains causing hand, foot and mouth disease (HFMD) in India
por: Tikute, Sanjaykumar, et al.
Publicado: (2023)

Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine
por: Li, Jingliang, et al.
Publicado: (2015)

The emergence and spread of one Coxsackievirus A16 Genogroup D novel recombinant strain that caused a clustering HFMD outbreak in Shanghai, China, 2016
por: Wang, Jiayu, et al.
Publicado: (2018)

Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China
por: Yu, Yuting, et al.
Publicado: (2021)

Identification of a nucleotide in 5′ untranslated region contributing to virus replication and virulence of Coxsackievirus A16
por: Li, Zhaolong, et al.
Publicado: (2016)

Rhombencephalitis and Coxsackievirus A16
por: Goto, Kazuna, et al.
Publicado: (2009)

Emerging recombination of the C2 sub-genotype of HFMD-associated CV-A4 is persistently and extensively circulating in China
por: Ji, Tianjiao, et al.
Publicado: (2019)

Coxsackievirus A16 in Southern Vietnam
por: Nhu, Le Nguyen Truc, et al.
Publicado: (2021)

Serotyping and Genetic Characterization of Hand, Foot, and Mouth Disease (HFMD)-Associated Enteroviruses of No-EV71 and Non-CVA16 Circulating in Fujian, China, 2011–2015
por: Weng, Yuwei, et al.
Publicado: (2017)

Molecular epidemiology of coxsackievirus A16 circulating in children in Beijing, China from 2010 to 2019
por: Hu, Ya-Fang, et al.
Publicado: (2021)

Retrospective Study of the Incidence of HFMD and Seroepidemiology of Antibodies against EV71 and CoxA16 in Prenatal Women and Their Infants
por: Zhu, Feng-Cai, et al.
Publicado: (2012)

Fatal Coxsackievirus A-16 Pneumonitis in Adult
por: Legay, François, et al.
Publicado: (2007)

In Vitro Characterization of Neutralizing Hen Antibodies to Coxsackievirus A16
por: Mwale, Pharaoh Fellow, et al.
Publicado: (2021)

Genomic epidemiology of coxsackievirus A16 in mainland of China, 2000–18
por: Han, Zhenzhi, et al.
Publicado: (2020)

Construction and characterization of an infectious clone of coxsackievirus A16
por: Liu, Fei, et al.
Publicado: (2011)

Molecular mechanism of antibody neutralization of coxsackievirus A16
por: Zhang, Chao, et al.
Publicado: (2022)

Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010
por: Ang, Li Wei, et al.
Publicado: (2015)

Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse model
por: Huang, L., et al.
Publicado: (2015)

Development and evaluation of an inactivated coxsackievirus A16 vaccine in gerbils
por: Sun, Yi-Sheng, et al.
Publicado: (2022)

Coxsackievirus A16 Encephalitis during Obinutuzumab Therapy, Belgium, 2013
por: Eyckmans, Tom, et al.
Publicado: (2014)

Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China
por: Li, Wei, et al.
Publicado: (2013)

Potential dual outbreak of COVID-19 and HFMD among children in Asia-Pacific countries in the HFMD-endemic area
por: Jiang, Lina, et al.
Publicado: (2021)

Coxsackievirus A16-like particles elicit neutralizing antibody responses in mice
por: Liu, Qingwei, et al.
Publicado: (2011)

Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China
por: Ji, Hong, et al.
Publicado: (2012)

Molecular Epidemiology of Coxsackievirus A16: Intratype and Prevalent Intertype Recombination Identified
por: Chen, Xiangpeng, et al.
Publicado: (2013)

Co-circulation of coxsackieviruses A-6, A-10, and A-16 causes hand, foot, and mouth disease in Guangzhou city, China
por: Xie, Jia, et al.
Publicado: (2020)

Coxsackievirus A16 Elicits Incomplete Autophagy Involving the mTOR and ERK Pathways
por: Shi, Yingying, et al.
Publicado: (2015)

Immunologic Characterization of Cytokine Responses to Enterovirus 71 and Coxsackievirus A16 Infection in Children
por: Zhang, Shu-Yan, et al.
Publicado: (2015)

Characterization of VP1 sequence of Coxsackievirus A16 isolates by Bayesian evolutionary method
por: Zhao, Guolian, et al.
Publicado: (2016)

Bioinformatics-based prediction of conformational epitopes for Enterovirus A71 and Coxsackievirus A16
por: Wang, Liping, et al.
Publicado: (2021)

A hSCARB2-transgenic mouse model for Coxsackievirus A16 pathogenesis
por: Chen, Yanli, et al.
Publicado: (2021)

Different Antibody Response against the Coxsackievirus A16 VP1 Capsid Protein: Specific or Non-Specific
por: Ding, Yingying, et al.
Publicado: (2016)

Genetic and Cross Neutralization Analyses of Coxsackievirus A16 Circulating in Taiwan from 1998 to 2021 Suggest Dominant Genotype B1 can Serve as Vaccine Candidate
por: Cheng, Dayna, et al.
Publicado: (2022)

Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum
por: Jin, Jun, et al.
Publicado: (2013)

A case report of severe systemic infection with neurological HFMD symptoms followed by an accidental puncture of thumb during HFMD sample collection
por: Zare, Maryam, et al.
Publicado: (2022)

HMGB1 is involved in viral replication and the inflammatory response in coxsackievirus A16-infected 16HBE cells via proteomic analysis and identification
por: Hu, Yajie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gtv1q9hrc6fp6dbgnj53ai3dob